$2.33 -0.01 (-0.43%)
11/27/2009 1:00 PM

DURECT Corp (DRRX)

CAPS Rating: 3 out of 5

The Company is a pharmaceutical Company developing therapies for the treatment of chronic diseases and conditions with its proprietary drug formulations and delivery platform technologies.

Featured Broker Partners